GENE - Genetic Technologies provides updates for June-quarter

2023-07-28 13:26:38 ET

• Genetic Technologies ( NASDAQ: GENE ) said Friday its June-quarter receipts were A$2.1 million.

• At the end of June 2023, the company had A$7.9 million in cash and cash equivalents.

• Cash receipts from customers for the financial year were A$8.8 million.

• The cash outflow used from operating activities was A$9.9 million for the financial year.

• The company received a net $6.3 million from the issue of equity early in the calendar year.

• Adoption of geneType continues to grow strongly in both Australia and the U.S., the company said.
• In the U.S., the company is progressing discussions to initiate a pilot study to determine the clinical utility of the geneType Breast Cancer Risk Assessment Test with a Midwest-based employer group.
• Press Release .

For further details see: